Covered recipient · General Payments record
ANDREW W THAYNE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$5,166.52
- Reported across 298 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $637.24 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $180.17 | 10 |
| Amgen Inc. | $75.22 | 5 |
| PFIZER INC. | $61.95 | 4 |
| Astellas Pharma US Inc | $52.05 | 2 |
| Mylan Specialty L.P. | $45.23 | 2 |
| Novo Nordisk AS | $42.09 | 3 |
| GlaxoSmithKline, LLC. | $36.66 | 2 |
| Merck Sharp & Dohme Corporation | $35.00 | 2 |
| Seqirus USA Inc | $26.39 | 1 |
| Neurocrine BioSciences, Inc. | $22.85 | 1 |
| Grifols USA, LLC | $22.37 | 1 |
| DEXCOM, INC. | $18.88 | 1 |
| Vanda Pharmaceuticals Inc. | $18.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.50 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106215392 | CMS |
| ABBVIE INC. | $20.37 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106215394 | CMS |
| ABBVIE INC. | $17.21 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106215396 | CMS |
| ABBVIE INC. | $18.64 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106215398 | CMS |
| ABBVIE INC. | $22.51 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106215400 | CMS |
| ABBVIE INC. | $19.50 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106215402 | CMS |
| ABBVIE INC. | $10.48 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106215404 | CMS |
| ABBVIE INC. | $21.41 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106215406 | CMS |
| ABBVIE INC. | $18.00 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106215408 | CMS |
| ABBVIE INC. | $15.55 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106215410 | CMS |
| Amgen Inc. | $17.00 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111724065 | CMS |
| Amgen Inc. | $13.27 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111724067 | CMS |
| Amgen Inc. | $13.20 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111724069 | CMS |
| Amgen Inc. | $15.50 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111724071 | CMS |
| Amgen Inc. | $16.25 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111724073 | CMS |
| Astellas Pharma US Inc | $30.77 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139371581 | CMS |
| Astellas Pharma US Inc | $21.28 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139275198 | CMS |
| Dexcom, Inc. | $18.88 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279633 | CMS |
| GlaxoSmithKline, LLC. | $18.16 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116596923 | CMS |
| GlaxoSmithKline, LLC. | $18.50 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116602085 | CMS |
| Grifols USA, LLC | $22.37 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124712794 | CMS |
| Merck Sharp & Dohme LLC | $17.21 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141599701 | CMS |
| Merck Sharp & Dohme LLC | $17.79 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141837714 | CMS |
| Mylan Specialty L.P. | $23.03 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147284314 | CMS |
| Mylan Specialty L.P. | $22.20 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147361985 | CMS |
| Neurocrine Biosciences, Inc. | $22.85 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150847093 | CMS |
| Novo Nordisk Inc | $14.42 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097714041 | CMS |
| Novo Nordisk Inc | $13.40 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096645799 | CMS |
| Novo Nordisk Inc | $14.27 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096825399 | CMS |
| PFIZER INC. | $15.47 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131553031 | CMS |
| PFIZER INC. | $13.77 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131489764 | CMS |
| PFIZER INC. | $13.78 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131633596 | CMS |
| PFIZER INC. | $18.93 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131777310 | CMS |
| Seqirus USA Inc | $26.39 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125630974 | CMS |
| Vanda Pharmaceuticals Inc. | $18.38 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133922994 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.